• 🌎 Worldwide
    • πŸ‡ΊπŸ‡Έ U.S.
    • πŸ‡¨πŸ‡¦ Canada
    • πŸ‡¬πŸ‡§ United Kingdom
    • 🌏 Asia
    • 🌍 Europe
    • 🌎 Latin America
    • 🌏 Oceania and Australasia
The Daily Marijuana Observer
SUBSCRIBE
  • Home
  • Latest
  • Business
  • Investments
  • Law
  • People
  • Health
  • Databases
No Result
View All Result
The Daily Marijuana Observer
  • Home
  • Latest
  • Business
  • Investments
  • Law
  • People
  • Health
  • Databases
No Result
View All Result
The Daily Marijuana Observer
No Result
View All Result
Home Investments

3 Cannabinoid Biotech Companies in ExodusPoint Capital Management’s Portfolio

There's also one cannabis biotech stock they avoided...

Steven Lachard by Steven Lachard
February 23, 2020
in ETFs and Funds, Investments, Marijuana Stocks, Trading
Cannabis Biotech Stocks News

Image by Michal Jarmoluk from Pixabay

143
SHARES
ShareShare

Founded in 2017 by Michael Gelband and Hyung Lee, ExodusPoint opened its doors to outside capital in 2018. Leveraging a multifaceted approach to investing, ExodusPoint raised over $8 billion for its debut and recently announced plans to raise $2 billion more back in November.

Combing through hundreds of different holdings comprising over $5 billion in managed 13F securities in the recent Form 13F-HR filed by Exoduspoint Capital Management, LP, we can see that the fund owns shares in three different biotech companies with cannabinoid-related drugs in development.

All three of the stocks are listed on the NASDAQ, which means that they can all be traded commission-free on Robinhood as well as many other brokerage platforms.

In alphabetical order…

Cara Therapeutics, Inc. (NASDAQ:CARA)

Cara’s product pipeline includes an in-development drug nicknamed CR701, which selectively modulates
peripheral cannabinoid receptors. Studies on the effects of cannabis have led to the discovery of an endogenous system of ligands in humans involved in a number of physiological processes, including pain and inflammation.

CR701 is a peripherally-restricted, mixed-CB1/CB2 receptor agonist that selectively interacts with these cannabinoid receptor subtypes with no-off target activities. The compound is orally bioavailable, active in preclinical models of inflammatory and neuropathic pain, and does not produce the side effects characteristic of centrally-active cannabinoids, such as sedation and hypothermia.

ExodusPoint Capital Management owns 20,755 shares of CARA as of the recent filing.

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP)

Out of a handful of drugs under development, Corbus’ product pipeline includes Lenabasum, is a rationally-designed, oral, small-molecule that selectively binds as an agonist to the CB2 cannabinoid receptors.

Lenabasum has demonstrated favorable safety and tolerability profiles in clinical studies to date, and additional clinical studies are being conducted and/or planned to confirm these results and support applications for regulatory approval.

ExodusPoint Capital Management owns 10,897 shares of CRBP as of the recent filing.

Zynerba Pharmaceuticals Inc. (NASDAQ:ZYNE)

Zynerba’s product pipeline includes two drugs being developed: ZYN001 and ZYN002. ZYN001 is a THC Pro-Drug Patch providing transdermal THC delivery for fibromyalgia and peripheral neuropathic pain. ZYN002 is a synthetic CBD gel providing transdermal non-psychoactive CBD delivery for epilepsy, osteoarthritis, as well as Fragile X syndrome.

ExodusPoint Capital Management owns 13,290 shares of ZYNE as of the recent filing.

One More!

In addition to the three stocks mentioned above, ExodusPoint Capital Management also owns 26,984 shares of AbbVie, Inc. (NYSE:ABBV).

Since the mid ’80s, AbbVie has marketed a drug called Marinol. Marinol is a dronabinol capsule that is chemically identical to tetrahydrocannabinol, a.k.a. THC.

Conclusion

While these four positions aren’t large relative to the fund’s massive size, we notice as much from the three cannabinoid biotech stocks they own as we do from the cannabinoid biotech stocks they don’t own.

For instance, ExodusPoint Capital Management doesn’t own any shares of GW Pharmaceuticals Plc (NASDAQ:GWPH), and they’re considered to be one of the leaders.

Be sure to subscribe to free cannabis stock updates here, or for free biotech-specific updates subscribe here.

Share this:

  • Click to email this to a friend (Opens in new window)
  • Click to share on Twitter (Opens in new window)
  • Click to share on Facebook (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)
  • Click to share on Reddit (Opens in new window)
  • Click to share on Telegram (Opens in new window)
  • Click to share on WhatsApp (Opens in new window)
  • Click to share on Pinterest (Opens in new window)
  • Click to share on Tumblr (Opens in new window)
  • Click to share on Pocket (Opens in new window)
Tags: AbbVie Inc.biotechCara Therapeutics Inc.Corbus Pharmaceuticals Holdings Inc.ExodusPoint Capital Management LPGW Pharmaceuticals Plc.Michael GelbandNASDAQ:CARANASDAQ:CRBPNASDAQ:GWPHNASDAQ:ZYNENYSE:ABBVZynerba Pharmaceuticals Inc.

Get Real-Time Updates from MJobserver.com

Unsubscribe
Steven Lachard

Steven Lachard

Steven Lachard is a staff writer for MJobserver.com with a particular focus on marijuana stocks. Beyond MJobserver.com, Steven's pot stock insights have been featured on TalkMarkets.com and more.

Related Posts

Epidiolex from GW Pharmaceuticals
Investments

Jazz Pharmaceuticals to Acquire GW Pharmaceuticals plc, Creating an Innovative, High-Growth, Global Biopharma Leader

February 3, 2021
Epidiolex from GW Pharmaceuticals
Investments

Greenwich Biosciences, Inc., a Subsidiary of GW Pharmaceuticals plc, Launches unspoken symphony, a Breakthrough Innovation Created for the US Epilepsy Community

October 21, 2020
Epidiolex from GW Pharmaceuticals
Executives

GW Pharmaceuticals Announces the Appointment of David Gryska to its Board of Directors

September 10, 2020
Marinol Dronabinol THC Pharmaceutical
Events

30+ Expert Speakers to Present at the 3rd Annual Cannabinoid-Derived Pharmaceuticals Summit

July 9, 2020
Cannabis Clinical Trials
Health

Drug Trial Planned For Synthetic Cannabinoid COVID-19 Treatment

June 8, 2020
Cannabis News - Marijuana Becomes Legal in Michigan Starting December 6th
Press Releases

GW Pharmaceuticals to Host Virtual Investor Event on Its Nabiximols U.S. Development Program and Market Opportunity

June 4, 2020
Load More
Next Post
The Flowr Corp. to Report Q4 and Fiscal Year-End 2018 Earnings - Cannabis Stocks News

Flowr Corp. Receives Approval to Double Capacity at Kelowna Facility

Leave a Comment! Cancel reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

🚨 Subscribe to Stock Alerts

Get Live Updates on Breaking News

Subscribe Now

βœ‰οΈ Subscribe to Our Newsletter!

* indicates required

πŸ”Ž Search Marijuana Stocks

πŸ“° Recent News

  • Verano Holdings Enters into Agreement to Expand Arizona Footprint
  • Green Thumb Industries Announces Initial Public Offering in the U.S. to Raise US$100,000,000
  • Greenlane Announces Dismissal of Remaining Securities Class Action
  • Indiva Reports Record Market Share for January 2021
  • Acreage Announces Fourth Quarter And Full Year 2020 Earnings Date
Facebook Twitter Instagram LinkedIn Youtube

Cannabis News by Region

  • πŸ‡ΊπŸ‡Έ United States
  • πŸ‡¨πŸ‡¦ Canada
  • πŸ‡¬πŸ‡§ United Kingdom
  • 🌏 Asia
  • 🌍 Europe
  • 🌎 Latin America
  • 🌏 Oceania and Australasia

Cannabis Tools & Resources

  • πŸ“… Calendar
  • πŸ“Š Databases
  • πŸ“‡ Directories
  • πŸ”” RSS Feeds
  • πŸ“Ί Videos

Find Cannabis Business Services

  • βš–οΈ Attorneys & Law Firms
  • πŸ“Š Accountants & Accounting Firms
  • πŸ’‘ Consultants & Consulting Firms
  • πŸ“² Marketing Agencies & Firms

The Daily Marijuana Observer

  • Subscribe
  • About MJobserver.com
  • Affiliate Marketing Disclosure
  • Legal Disclaimer
  • Privacy Policy
  • Contact Us

Advertise with Us

  • πŸ‘€ Advertise
  • πŸ“£ DMO Newswire
  • πŸ“‡ List in Our Databases

Β© 2018 - 2021 D.M.O. Holdings Corp.
DISCLAIMER: DMO Holdings Corp., which owns The Daily Marijuana Observerβ„’ (MJobserver.com), is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. DMO Holdings Corp., which owns MJobserver.com, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. Before making specific investment decisions, readers should seek their own professional advice and that of their own professional financial adviser. DMO Holdings Corp. or its affiliates, which owns MJobserver.com, may be compensated for its services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two.

No Result
View All Result
  • Home
  • Latest
  • πŸ”’ PRO
    • πŸ”’ A.M. Watchlist
    • πŸ”’ Analyst Action
  • πŸ’Ό Business
  • πŸ“ˆ Investments
    • πŸ“ˆ Stocks
    • πŸ’° ETFs and Funds
    • πŸ’­ Market Commentary
    • πŸ“° Press Releases
    • πŸ“… Earnings Calendar
  • βš–οΈ Law
    • Laws
    • Politics
    • Intellectual Property
    • Attorneys & Law Firms Database
  • πŸ‘₯ People
    • ⚽ Athletes
    • πŸ’Ό Executives
    • 🌟 Celebrities
    • πŸ›’ Consumers
    • βš•οΈ Doctors
    • πŸ’Š Patients
  • πŸ’Š Health
  • πŸ“‡ Databases
    • πŸ“ˆ Stock Databases
    • πŸ’° Fund Databases
    • πŸ’Ό Service Providers Databases
    • 🏦 Marijuana Stock Brokers
    • πŸ’² Marijuana Cryptocurrencies

Β© 2018 - 2021 D.M.O. Holdings Corp.
DISCLAIMER: DMO Holdings Corp., which owns The Daily Marijuana Observerβ„’ (MJobserver.com), is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. DMO Holdings Corp., which owns MJobserver.com, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. Before making specific investment decisions, readers should seek their own professional advice and that of their own professional financial adviser. DMO Holdings Corp. or its affiliates, which owns MJobserver.com, may be compensated for its services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two.

Login to your account below

Forgotten Password? Sign Up

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In
loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.